Divi’s Labs net rises 29% on higher income
The Hindu
Drugmaker Divi’s Laboratories reported consolidated net profit rose 29% to ₹502 crore for the quarter ended March. It came on the back of the total income increasing 24% to ₹1,811.7 crore.For FY21, th
Drugmaker Divi’s Laboratories reported consolidated net profit rose 29% to ₹502 crore for the quarter ended March. It came on the back of the total income increasing 24% to ₹1,811.7 crore. For FY21, the net profit rose 44% to ₹1,984.3 crore. Total revenue increased 26% to ₹7,032 crore. The company has declared a dividend of ₹20 a share .More Related News
Air India has signed an agreement with Bengaluru Airport City Limited (BACL), a subsidiary of Bangalore International Airport Limited (BIAL), to develop a built-to-suit facility for the AME program that will feature modern classrooms, well-equipped laboratories for practical training and a team of qualified trainers.